Shanele Vaughn, MD
Interventional Pain Medicine · Oak Lawn, ILNPI 1902194822
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $226 and has fallen 83.0% since, to $38 in 2023. That places this record below the midpoint for interventional pain medicine clinicians in IL, where the typical reported total is $2,254.
Across 29 payments — averaging $20.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$100
- Abbott$89
- Novartis$87
- Collegium Pharmaceutical, Inc.$44
- Biogen$39
- Teva Pharmaceuticals USA, Inc.$36
- plus $194 from 8 others
What the payments were for
- Food & beverage$590100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 5 | $100 |
| Abbott | 1 | $89 |
| Novartis | 5 | $87 |
| Collegium Pharmaceutical, Inc. | 3 | $44 |
| Biogen | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Livanova USA, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $29 |
| Amgen | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| GSK | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
How this compares
$590 in reported general payments places this provider in the 25th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Oak Lawn
- Rifat KhanOak Lawn$997
- Ahmed ZakiOak Lawn$995
- Alexander FeoktistovNorthfield$922K
- Timothy LubenowChicago$556K
- Sandeep AminChicago$430K
- Matthew JaycoxChicago$123K
- Hong VoChicago$91K
- Asokumar BuvanendranChicago$52K
- Ramsin BenyaminBloomington$32K
- Adam YoungChicago$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.